Links to articles in the current and previous 2 issues of this bulletin are displayed below.
To receive email notifications about new issues of this bulletin, please email: richard.fallis@healthcarelibrary.qub.ac.uk
Adolescent psychedelic use and psychotic or manic symptoms 10.1001/jamapsychiatry.2024.0047
Adverse childhood experiences and adult mental health outcomes 10.1001/jamapsychiatry.2024.0039
A dynamical systems view of psychiatric disorders—theory 10.1001/jamapsychiatry.2024.0215
See also: A dynamical systems view of psychiatric disorders—practical implications 10.1001/jamapsychiatry.2024.0228
Essentials of informed consent to psychedelic medicine 10.1001/jamapsychiatry.2024.0184
Genetic and phenotypic features of schizophrenia in the UK Biobank 10.1001/jamapsychiatry.2024.0200
Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia‐spectrum disorders (Cochrane review) 10.1002/14651858.CD013425.pub2
How can we support staff after the death by suicide of a colleague? 10.1136/bmj.q1049
Incidence of antidepressant discontinuation symptoms 10.1016/S2215-0366(24)00133-0
Integrated care van delivery of evidence-based services for people who inject drugs: a cluster-randomized trial 10.1111/add.16486
Opportunistic smoking cessation interventions for people accessing financial support settings: a scoping review 10.1111/add.16533
The perspectives of hospital doctors about end-of-life care in people with mental illness: an observational pilot study 10.1111/imj.16294
Prevalence of mental health disorders among individuals experiencing homelessness: a systematic review and meta-analysis 10.1001/jamapsychiatry.2024.0426
Prevalence of opioid dependence in Scotland 2015–2020: a multi-parameter estimation of prevalence (MPEP) study 10.1111/add.16500
Preventing posttraumatic stress disorder following childbirth: a systematic review and meta-analysis 10.1016/j.ajog.2023.12.013
Psychological and psychosocial interventions for treatment-resistant schizophrenia: a systematic review and network meta-analysis 10.1016/S2215-0366(24)00136-6
The risk relationships between alcohol consumption, alcohol use disorder and alcohol use disorder mortality: a systematic review and meta-analysis 10.1111/add.16456
Suicide prevention: reflections on progress over the past decade 10.1016/S2215-0366(24)00105-6
Trajectories of adolescent media use and their associations with psychotic experiences 10.1001/jamapsychiatry.2024.0384
Worldwide incidence of suicides in prison 10.1016/S2215-0366(24)00134-2
Addiction (Jul-Aug); American Journal of Obstetrics and Gynecology (Jun); BMJ, The (13th May); Cochrane Library (Jun); Internal Medicine Journal (May); JAMA Psychiatry (Jun-Jul); Lancet Psychiatry, The (Jun-Jul)
5-year mental health outcomes for children and adolescents presenting with psychiatric symptoms to general practitioners in England 10.1016/S2215-0366(24)00038-5
Collaborative care approaches for people with severe mental illness (updated Cochrane review) 10.1002/14651858.CD009531.pub3
Components and delivery formats of cognitive behavioral therapy for chronic insomnia in adults 10.1001/jamapsychiatry.2023.5060
Comprehensive vaping bans are associated with lower odds of initiation into electronic nicotine delivery systems use among young people 10.1111/add.16450
Cost-effectiveness of therapist-assisted internet-delivered psychological therapies for PTSD differing in trauma focus in England 10.1016/S2215-0366(24)00055-5
Does this patient have alcohol use disorder? The Rational Clinical Examination systematic review 10.1001/jama.2024.3101
Efficacy and safety of alcohol reduction pharmacotherapy according to treatment duration in patients with alcohol dependence or alcohol use disorder 10.1111/add.16421
Efficacy of psilocybin for treating symptoms of depression 10.1136/bmj-2023-078084
The impact of COVID-19 pandemic on gambling 10.1016/j.addbeh.2024.108037
Impact of drought on mental and behavioral disorders, contributions of research in a climate change context 10.1007/s00484-024-02657-x
Multiple adverse outcomes associated with antipsychotic use in people with dementia 10.1136/bmj-2023-076268
Perceived misdiagnosis of psychiatric conditions in autistic adults 10.1016/j.eclinm.2024.102586
Prioritizing maternal mental health in addressing morbidity and mortality 10.1001/jamapsychiatry.2023.5648
Problematic pornography use across countries, genders, and sexual orientations 10.1111/add.16431
Psychosocial and medication interventions to stop or reduce alcohol consumption during pregnancy (new Cochrane review) 10.1002/14651858.CD015042.pub2
Repetitive behaviors in autism and obsessive-compulsive disorder 10.1007/s10803-024-06357-8
Restricting alcohol marketing to reduce alcohol consumption 10.1111/add.16411
Risk assessment for aggressive behaviour in schizophrenia (new Cochrane review) 10.1002/14651858.CD012397.pub2
Why are females less likely to be diagnosed with ADHD in childhood than males? 10.1016/S2215-0366(24)00010-5
Worldwide prevalence and disability from mental disorders across childhood and adolescence: evidence from the Global Burden of Disease Study 10.1001/jamapsychiatry.2023.5051
Addiction (May-Jun); Addictive Behaviors (Aug); BMJ, The (Apr-May); Cochrane Library (Apr-May); eClinicalMedicine (Apr); JAMA (9th Apr); JAMA Psychiatry (Apr-May); International Journal of Biometeorology (Mar); Journal of Autism and Developmental Disorders (Apr); Lancet Psychiatry, The (Apr-May)
All-cause and cause-specific mortality among individuals with hypochondriasis 10.1001/jamapsychiatry.2023.4744
Associations of the gut microbiome with treatment resistance in schizophrenia 10.1001/jamapsychiatry.2023.5371
Community perinatal mental health teams and associations with perinatal mental health and obstetric and neonatal outcomes in pregnant women with a history of secondary mental health care in England 10.1016/S2215-0366(23)00409-1
Digitally augmented, parent-led CBT versus treatment as usual for child anxiety problems in child mental health services in England and Northern Ireland 10.1016/S2215-0366(23)00429-7
Digitally enabled therapies for adults with depression: early value assessment (updated NICE guideline HTE8 – 12th February 2024)
The effect of immigration policy reform on mental health in people from minoritised ethnic groups in England 10.1016/S2215-0366(23)00412-1
Effectiveness of culturally tailoring smoking cessation interventions for reducing or quitting combustible tobacco 10.1111/add.16400
Evaluation of the effectiveness of cytisine for the treatment of smoking cessation 10.1111/add.16399
Identifying patients with opioid use disorder using International Classification of Diseases (ICD) codes: Challenges and opportunities 10.1111/add.16338
Pharmacological treatments for psychotic depression 10.1016/S2215-0366(24)00006-3
Prescription psychostimulants for the treatment of amphetamine-type stimulant use disorder 10.1111/add.16347
Promoting good mental health over the menopause transition 10.1016/S0140-6736(23)02801-5
Psychosocial interventions for stimulant use disorder (updated Cochrane review) 10.1002/14651858.CD011866.pub3
Psychotherapies for generalized anxiety disorder in adults 10.1001/jamapsychiatry.2023.3971
The role of socioeconomic position in the association between mental disorders and mortality 10.1001/jamapsychiatry.2023.4316
Treatment outcomes with licensed and unlicensed stimulant doses for adults with Attention-Deficit/Hyperactivity Disorder 10.1001/jamapsychiatry.2023.3985
Addiction (Jan-Apr); Cochrane Library (Feb-Mar); JAMA Psychiatry (Feb-Mar); Lancet, The (9th-15th Mar); Lancet Psychiatry, The (Mar); NICE website (Jan-Mar)